ONCOCYTE CORP
IMDX·68235C206·US·Common Stock·Healthcare - Diagnostics & Research-Activist
IMDX (ONCOCYTE CORP) is held by 25 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($4.3M), GEODE CAPITAL MANAGEMENT, LLC ($1.5M), JANE STREET GROUP, LLC ($930,324). Net institutional sentiment: Mixed.
25
Holders
$11M
Total Value
54% (28)
Consensus
15 buying - 13 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders Jul 6, 2026 · Activists Apr 27, 2026 · Congress none
InsiderLJLast Andrew J.Tax 8K shJul 1, 2026
InsiderAAArno AndrewTax 12K shJul 1, 2026
InsiderSLSILVERMAN LOUTax 8K shJul 1, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 33
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer